Introduction Oligonucleotides (ONs) are an important therapeutic modality within the medical toolbox for treating various diseases1,2,3. Currently, seventeen RNA-targeting ON therapeutics have been approved by […]
Introduction Oligonucleotides (ONs) are an important therapeutic modality within the medical toolbox for treating various diseases1,2,3. Currently, seventeen RNA-targeting ON therapeutics have been approved by […]